Endoscopic Devices - Bangladesh | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Bangladesh is anticipated to amount to US$18.85m in 2024.
The revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 10.24%, leading to a market volume of US$30.69m by 2029.
In a global context, the majority of revenue is expected to be generated the United States, with a figure of US$10.39bn in 2024.
In Bangladesh, the rising prevalence of gastrointestinal disorders is significantly driving the demand for advanced endoscopic devices within the medical technology sector.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market within the Medical Devices sector in Bangladesh is experiencing moderate growth, influenced by factors such as increasing healthcare investments, a rising prevalence of chronic diseases, and advancements in minimally invasive surgical technologies.

Customer preferences: In Bangladesh, there is a growing preference for advanced healthcare solutions, particularly in the realm of endoscopic devices, as patients become more informed about their treatment options. This shift is partly driven by an increasing awareness of the benefits of minimally invasive procedures, which promise quicker recovery times and less discomfort. Additionally, the aging population is increasingly seeking specialized healthcare services, prompting a demand for innovative endoscopic technologies. Cultural attitudes towards health and wellness are evolving, with more individuals prioritizing preventive care and early diagnosis, further fueling market growth.

Trends in the market: In Bangladesh, the endoscopic devices market is experiencing significant growth, driven by advancements in technology and an increasing demand for minimally invasive surgical procedures. More healthcare facilities are adopting innovative endoscopic solutions, enhancing diagnostic accuracy and patient outcomes. Additionally, there is a notable rise in training programs for healthcare professionals to ensure proficient use of these devices. As patients become more proactive about their health, the emphasis on preventive care and early detection is reshaping the landscape, presenting opportunities for manufacturers and investors to expand their offerings and improve accessibility in the healthcare system.

Local special circumstances: In Bangladesh, the endoscopic devices market is influenced by a growing urban population and limited healthcare infrastructure in rural areas, driving demand for efficient diagnostic solutions. Cultural attitudes toward health are evolving, with an increasing acceptance of minimally invasive procedures among patients. Regulatory frameworks are gradually adapting to support the introduction of advanced medical technologies, fostering partnerships between local and international companies. These factors create a unique environment for innovation, enhancing access to quality healthcare and improving patient outcomes across diverse demographics.

Underlying macroeconomic factors: The Endoscopic Devices Market in Bangladesh is significantly influenced by macroeconomic factors such as increasing healthcare expenditure, urbanization, and the rising prevalence of gastrointestinal disorders. The national economic health, characterized by steady GDP growth, encourages investments in healthcare infrastructure, while fiscal policies aimed at improving public health services bolster demand for advanced medical technologies. Furthermore, global trends in minimally invasive procedures and enhanced patient safety are prompting local stakeholders to adopt innovative endoscopic solutions. These dynamics collectively enhance market performance, ultimately improving healthcare access and outcomes for the population.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.